Schizophrenia Treatment Study

Researchers are partnering with individuals diagnosed with schizophrenia or schizoaffective disorder to evaluate how a medication can help. Join our compensated study today!

Fast Facts

schizophrenia or schizoaffective disorder

18-65 years old

Compensation Provided

Manhattan Psychiatric Center

Study Background

This research study will investigate an FDA approved antipsychotic medication called clozapine in individuals with schizophrenia and schizoaffective disorder.

Not all participants will receive clozapine. Some will receive a different antipsychotic medication. The decision of which one you receive will be random, like flipping a coin.

Your participation in this study may help future researchers improve treatment approaches for schizophrenia. Further research today and join our compensated study!

Additional Information

The purpose of this research study is to examine the effects of treatment with clozapine vs antipsychotic treatment as usual for adults with schizophrenia.

You may qualify for this study if you meet the following criteria.

Key Criteria:

  • Diagnosed with schizophrenia or schizoaffective disorder
  • 18-65 years old
  • No allergy to clozapine
  • No unstable medical or neurological conditions
  • Not pregnant or nursing

Once enrolled, this 24-week study involves:

  • Baseline assessment and medical screening
  • Randomization into one of two study groups
  • Receiving either clozapine or another antipsychotic medication
  • Weekly study visits for 6 months (24 weeks)

Compensation up to $950 is provided for your time.

There is no cost for you to participate in this study.